BAFF Is Increased in Renal Transplant Patients Following Treatment with Alemtuzumab

Por Bloom, D., Chang, Z., Pauly, K., Kwun, J., Fechner, J., Hayes, C., Samaniego, M., Knechtle, S.
Publicado no Am J Transplant (2009)

Neutralizing BAFF/APRIL With Atacicept Prevents Early DSA Formation and AMR Development in T Cell Depletion Induced Nonhuman Primate AMR Model

Por Kwun, J., Page, E., Hong, J. J., Gibby, A., Yoon, J., Farris, A. B., Villinger, F., Knechtle, S.
Publicado no Am J Transplant (2015)

Enhanced de novo alloantibody and antibody-mediated injury in rhesus macaques

Por Page, EK, Page, AJ, Kwun, J, Gibby, AC, Leopardi, F, Jenkins, JB, Strobert, EA, Song, M, Hennigar, RA, Iwakoshi, N, Knechtle, SJ
Publicado no Am J Transplant (2012)

Patterns of De Novo Allo B Cells and Antibody Formation in Chronic Cardiac Allograft Rejection After Alemtuzumab Treatment

Por Kwun, J., Oh, B. C., Gibby, A. C., Ruhil, R., Lu, V. T., Kim, D. W., Page, E. K., Bulut, O. P., Song, M. Q., Farris, A. B., Kirk, A. D., Knechtle, S. J., Iwakoshi, N. N.
Publicado no Am J Transplant (2012)